2007
DOI: 10.1111/j.1365-2036.2007.03413.x View full text |Buy / Rent full text
|
|

Abstract: SUMMARYBackground Lifelong adherence to a strict gluten-free diet is the cornerstone of coeliac disease treatment. Elucidation of disease pathogenesis has created opportunities for novel therapeutic approaches to coeliac disease. AT-1001 is an inhibitor of paracellular permeability whose structure is derived from a protein secreted by Vibrio cholerae.

Help me understand this report

Search citation statements

Order By: Relevance
Select...
2
166
0
7

Publication Types

Select...

Relationship

0
0

Authors

Journals